METHOD FOR NEURALGIA TREATMENT Russian patent published in 2017 - IPC A61K31/192 A61K31/4152 A61K31/472 A61K31/573 A61K31/5415 A61K31/714 A61P25/02 

FIELD: medicine.

SUBSTANCE: for neuralgia treatment, a drug complex is used, where one of non-steroidal anti-inflammatory compounds drugs is applied as the basic analgesic agents, namely - ketorolac tromethamine at a dose of 15-75 mg, or sodium metamizole at a dose of 500-2500 mg, or the ketoprofen at a dose of 50-250 mg, or dexketoprofen at a dose of 25-125 mg, or lornoxicam at a dose of 4-20 mg, cyanocobalamin at a dose of 500-2500 mcg is used as an adjuvant analgesic agent, and drotaverine hydrochloride at a dose of 10-50 m is used as a myotropic spasmolytic action, that are administered intravenously with distribution of the said doses by one or two daily injectios, course of treatment lasts 1-10 days.

EFFECT: method allows to ensure complete elimination of the pain syndrome after the course of treatment, the possibility of pain syndrome elimination with a single administration of drugs with obtaining of a momentary stable analgesic effect by eliminating the protective muscular tension in the affected nerve zone at method safety.

2 tbl, 125 ex